Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas

Massimo Mannelli, Maurizio Castellano, Francesca Schiavi, Sebastiano Filetti, Mara Giacchè, Luigi Mori, Viviana Pignataro, Gianpaolo Bernini, Valentino Giachè, Alessandra Bacca, Bernadette Biondi, Giovanni Corona, Giuseppe Di Trapani, Erika Grossrubatscher, Giuseppe Reimondo, Giorgio Arnaldi, Gilberta Giacchetti, Franco Veglio, Paola Loli, Annamaria ColaoMaria Rosaria Ambrosio, Massimo Terzolo, Claudio Letizia, Tonino Ercolino, Giuseppe Opocher

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

Purpose: The aim of the study was to define the frequency of hereditary forms and the genotype/phenotype correlations in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Design: We examined 501 consecutive patients with pheochromocytomas and/or paragangliomas (secreting or nonsecreting). Complete medical and family histories, as well as the results of clinical, laboratory, and imaging studies, were recorded in a database. Patients were divided into different groups according to their family history, the presence of lesions outside adrenals/paraganglia considered syndromic for VHL disease, MEN2, and NF1, and the number and types of pheochromocytomas and/or paragangliomas. Germ-line mutations in known susceptibility genes were investigated by gene sequencing (VHL, RET, SDHB, SDHC, SDHD) or diagnosed according to phenotype (NF1). In 160 patients younger than 50 yr with a wild-type profile, multiplex ligation-dependent probe amplification assays were performed to detect genomic rearrangements. Results: Germline mutations were detected in 32.1% of cases, but frequencies varied widely depending on the classification criteria and ranged from 100% in patients with associated syndromic lesions to 11.6% in patients with a single tumor and a negative family history. The types and number of pheochromocytomas/paragangliomas as well as age at presentation and malignancy suggest which gene should be screened first. Genomic rearrangements were found in two of 160 patients (1.2%). Conclusions: The frequency of the hereditary forms of pheochromocytoma/paraganglioma varies dependingonthe family history and the clinical presentation. A positive family history and an accurate clinical evaluation of patients are strong indicators of which genes should be screened first.

Original languageEnglish
Pages (from-to)1541-1547
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume94
Issue number5
DOIs
Publication statusPublished - May 2009

Fingerprint

Paraganglioma
Genetic Testing
Pheochromocytoma
Screening
Genes
Clinical laboratories
Germ-Line Mutation
Medical imaging
Amplification
Tumors
Assays
Medical History Taking
Multiplex Polymerase Chain Reaction
Genetic Association Studies
Neoplasms
Databases
Phenotype

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. / Mannelli, Massimo; Castellano, Maurizio; Schiavi, Francesca; Filetti, Sebastiano; Giacchè, Mara; Mori, Luigi; Pignataro, Viviana; Bernini, Gianpaolo; Giachè, Valentino; Bacca, Alessandra; Biondi, Bernadette; Corona, Giovanni; Di Trapani, Giuseppe; Grossrubatscher, Erika; Reimondo, Giuseppe; Arnaldi, Giorgio; Giacchetti, Gilberta; Veglio, Franco; Loli, Paola; Colao, Annamaria; Ambrosio, Maria Rosaria; Terzolo, Massimo; Letizia, Claudio; Ercolino, Tonino; Opocher, Giuseppe.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 5, 05.2009, p. 1541-1547.

Research output: Contribution to journalArticle

Mannelli, M, Castellano, M, Schiavi, F, Filetti, S, Giacchè, M, Mori, L, Pignataro, V, Bernini, G, Giachè, V, Bacca, A, Biondi, B, Corona, G, Di Trapani, G, Grossrubatscher, E, Reimondo, G, Arnaldi, G, Giacchetti, G, Veglio, F, Loli, P, Colao, A, Ambrosio, MR, Terzolo, M, Letizia, C, Ercolino, T & Opocher, G 2009, 'Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas', Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 5, pp. 1541-1547. https://doi.org/10.1210/jc.2008-2419
Mannelli, Massimo ; Castellano, Maurizio ; Schiavi, Francesca ; Filetti, Sebastiano ; Giacchè, Mara ; Mori, Luigi ; Pignataro, Viviana ; Bernini, Gianpaolo ; Giachè, Valentino ; Bacca, Alessandra ; Biondi, Bernadette ; Corona, Giovanni ; Di Trapani, Giuseppe ; Grossrubatscher, Erika ; Reimondo, Giuseppe ; Arnaldi, Giorgio ; Giacchetti, Gilberta ; Veglio, Franco ; Loli, Paola ; Colao, Annamaria ; Ambrosio, Maria Rosaria ; Terzolo, Massimo ; Letizia, Claudio ; Ercolino, Tonino ; Opocher, Giuseppe. / Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 5. pp. 1541-1547.
@article{cb611c3e8ec046d78387b0aa2bd5bdef,
title = "Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas",
abstract = "Purpose: The aim of the study was to define the frequency of hereditary forms and the genotype/phenotype correlations in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Design: We examined 501 consecutive patients with pheochromocytomas and/or paragangliomas (secreting or nonsecreting). Complete medical and family histories, as well as the results of clinical, laboratory, and imaging studies, were recorded in a database. Patients were divided into different groups according to their family history, the presence of lesions outside adrenals/paraganglia considered syndromic for VHL disease, MEN2, and NF1, and the number and types of pheochromocytomas and/or paragangliomas. Germ-line mutations in known susceptibility genes were investigated by gene sequencing (VHL, RET, SDHB, SDHC, SDHD) or diagnosed according to phenotype (NF1). In 160 patients younger than 50 yr with a wild-type profile, multiplex ligation-dependent probe amplification assays were performed to detect genomic rearrangements. Results: Germline mutations were detected in 32.1{\%} of cases, but frequencies varied widely depending on the classification criteria and ranged from 100{\%} in patients with associated syndromic lesions to 11.6{\%} in patients with a single tumor and a negative family history. The types and number of pheochromocytomas/paragangliomas as well as age at presentation and malignancy suggest which gene should be screened first. Genomic rearrangements were found in two of 160 patients (1.2{\%}). Conclusions: The frequency of the hereditary forms of pheochromocytoma/paraganglioma varies dependingonthe family history and the clinical presentation. A positive family history and an accurate clinical evaluation of patients are strong indicators of which genes should be screened first.",
author = "Massimo Mannelli and Maurizio Castellano and Francesca Schiavi and Sebastiano Filetti and Mara Giacch{\`e} and Luigi Mori and Viviana Pignataro and Gianpaolo Bernini and Valentino Giach{\`e} and Alessandra Bacca and Bernadette Biondi and Giovanni Corona and {Di Trapani}, Giuseppe and Erika Grossrubatscher and Giuseppe Reimondo and Giorgio Arnaldi and Gilberta Giacchetti and Franco Veglio and Paola Loli and Annamaria Colao and Ambrosio, {Maria Rosaria} and Massimo Terzolo and Claudio Letizia and Tonino Ercolino and Giuseppe Opocher",
year = "2009",
month = "5",
doi = "10.1210/jc.2008-2419",
language = "English",
volume = "94",
pages = "1541--1547",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas

AU - Mannelli, Massimo

AU - Castellano, Maurizio

AU - Schiavi, Francesca

AU - Filetti, Sebastiano

AU - Giacchè, Mara

AU - Mori, Luigi

AU - Pignataro, Viviana

AU - Bernini, Gianpaolo

AU - Giachè, Valentino

AU - Bacca, Alessandra

AU - Biondi, Bernadette

AU - Corona, Giovanni

AU - Di Trapani, Giuseppe

AU - Grossrubatscher, Erika

AU - Reimondo, Giuseppe

AU - Arnaldi, Giorgio

AU - Giacchetti, Gilberta

AU - Veglio, Franco

AU - Loli, Paola

AU - Colao, Annamaria

AU - Ambrosio, Maria Rosaria

AU - Terzolo, Massimo

AU - Letizia, Claudio

AU - Ercolino, Tonino

AU - Opocher, Giuseppe

PY - 2009/5

Y1 - 2009/5

N2 - Purpose: The aim of the study was to define the frequency of hereditary forms and the genotype/phenotype correlations in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Design: We examined 501 consecutive patients with pheochromocytomas and/or paragangliomas (secreting or nonsecreting). Complete medical and family histories, as well as the results of clinical, laboratory, and imaging studies, were recorded in a database. Patients were divided into different groups according to their family history, the presence of lesions outside adrenals/paraganglia considered syndromic for VHL disease, MEN2, and NF1, and the number and types of pheochromocytomas and/or paragangliomas. Germ-line mutations in known susceptibility genes were investigated by gene sequencing (VHL, RET, SDHB, SDHC, SDHD) or diagnosed according to phenotype (NF1). In 160 patients younger than 50 yr with a wild-type profile, multiplex ligation-dependent probe amplification assays were performed to detect genomic rearrangements. Results: Germline mutations were detected in 32.1% of cases, but frequencies varied widely depending on the classification criteria and ranged from 100% in patients with associated syndromic lesions to 11.6% in patients with a single tumor and a negative family history. The types and number of pheochromocytomas/paragangliomas as well as age at presentation and malignancy suggest which gene should be screened first. Genomic rearrangements were found in two of 160 patients (1.2%). Conclusions: The frequency of the hereditary forms of pheochromocytoma/paraganglioma varies dependingonthe family history and the clinical presentation. A positive family history and an accurate clinical evaluation of patients are strong indicators of which genes should be screened first.

AB - Purpose: The aim of the study was to define the frequency of hereditary forms and the genotype/phenotype correlations in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Design: We examined 501 consecutive patients with pheochromocytomas and/or paragangliomas (secreting or nonsecreting). Complete medical and family histories, as well as the results of clinical, laboratory, and imaging studies, were recorded in a database. Patients were divided into different groups according to their family history, the presence of lesions outside adrenals/paraganglia considered syndromic for VHL disease, MEN2, and NF1, and the number and types of pheochromocytomas and/or paragangliomas. Germ-line mutations in known susceptibility genes were investigated by gene sequencing (VHL, RET, SDHB, SDHC, SDHD) or diagnosed according to phenotype (NF1). In 160 patients younger than 50 yr with a wild-type profile, multiplex ligation-dependent probe amplification assays were performed to detect genomic rearrangements. Results: Germline mutations were detected in 32.1% of cases, but frequencies varied widely depending on the classification criteria and ranged from 100% in patients with associated syndromic lesions to 11.6% in patients with a single tumor and a negative family history. The types and number of pheochromocytomas/paragangliomas as well as age at presentation and malignancy suggest which gene should be screened first. Genomic rearrangements were found in two of 160 patients (1.2%). Conclusions: The frequency of the hereditary forms of pheochromocytoma/paraganglioma varies dependingonthe family history and the clinical presentation. A positive family history and an accurate clinical evaluation of patients are strong indicators of which genes should be screened first.

UR - http://www.scopus.com/inward/record.url?scp=66149098136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149098136&partnerID=8YFLogxK

U2 - 10.1210/jc.2008-2419

DO - 10.1210/jc.2008-2419

M3 - Article

C2 - 19223516

AN - SCOPUS:66149098136

VL - 94

SP - 1541

EP - 1547

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -